Abstract:Abstract Background: The mammalian target of rapamycin complex 1 (mTORC1) is a pivotal regulator of cell growth and proliferation in response to nutrition and various factor. In recent years, studies have focus on over-activation of mTORC1 in normal cells leading to tumorigenesis and malignant tumor development. However, the precise factors of mTORC1 hyperactivation to promote the growth of hepatocellular carcinoma (HCC) or other cancers are still not well characterized. Thus, in this study, we aimed to clarify a novel gene -Rab1A, and it's expression and functional role in mTORC1 signal in of HCC. Methods: We analyzed the Rab1A protein in HCC and para-cancer samples from 143 patients and the correlation with its survival. To identify Rab1A's role in tumor progression, a serious of functional study were applied including overexpression and knockdown Rab1A in different cell lines both in vivo and in vitro. For mechanism research, western bolt was demonstrated to identify the signal dysregulation between Rab1A abnormity and mTORC1 pathway under involvement of irritants. Results: Our results showed that, compared with normal livers, Rab1A was frequently overexpressed in HCC and significantly associated with HCC prognosis. Functional study demonstrated that overexpression of Rab1A in HCC cells increased cell growth, cell migration, cell cycle progression and tumor formation in vivo and/or in vitro, all of which were effectively inhibited when Rab1A was silenced by shRNA. We further provided evidences that Rab1A promotes HCC growth and migration through phosphorylation of S6K, the consequence of activating mTORC1 signaling pathway. Mechanism research of the signal pathway between Rab1A and mTORC1 suggest that Rab1A is likely to stimulate mTORC1 directly, with the cooperation of Amino acid stimulation but not depend on the pathway of PI3K/AKT and MAPK/ERK.. Citation Format: Bi-Hong Xu, Xiao-Xing Li, Hui-yun Wang, X.F. Steven Zheng. Overexpressed Rab1A is associated poor prognosis and promotes oncogenic growth and metastasis through mTORC1 activation in hepatocellular carcinoma. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2053. doi:10.1158/1538-7445.AM2015-2053

Rab1A is an Mtorc1 Activator and a Colorectal Oncogene.

Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A

Rab1A Promotes Proliferation and Migration Abilities Via Regulation of the HER2/AKT-independent Mtor/s6k1 Pathway in Colorectal Cancer.

Amino Acid Regulation of TOR Complex 1.

Abstract 2053: Overexpressed Rab1A is Associated Poor Prognosis and Promotes Oncogenic Growth and Metastasis Through Mtorc1 Activation in Hepatocellular Carcinoma

The Ubiquitination of Rag A GTPase by RNF152 Negatively Regulates Mtorc1 Activation.

Expression analysis and implication of Rab1A in gastrointestinal relevant tumor

Regulation Of Mtorc1 By The Rab And Arf Gtpases

Abstract 1029: Rab1A and Rab1B Promote Esophageal Squamous Cell Carcinoma Through Activating Mtorc1 Signaling and Inhibiting Autophagy

Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids

Rheb1 Promotes Tumor Progression Through Mtorc1 in MLL-AF9-initiated Murine Acute Myeloid Leukemia

Rab5a Activates IRS1 to Coordinate IGF-AKT-mTOR Signaling and Myoblast Differentiation During Muscle Regeneration.

Aberrant Expression of Rab1A and Its Prognostic Significance in Human Colorectal Cancer

β-Arrestin-1-dependent activation of extracellular signal-regulated kinases in RON receptor-mediated tumorigenic activities in colon cancer cells

The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling.

RAB1A Regulates Glioma Cellular Proliferation and Invasion Via the Mtor Signaling Pathway and Epithelial-Mesenchymal Transition.

TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling

Expression of Rab1A is Upregulated in Human Lung Cancer and Associated with Tumor Size and T Stage

RAB27B Controls Palmitoylation-Dependent NRAS Trafficking and Signaling in Myeloid Leukemia

Rab1 in cell signaling, cancer and other diseases

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma